MM_Hub: CONGRESS|#EHA2021|@Cristin53875581, determined that the addition of QW SEL to the PI carfilzomib (CAR)-dex (XKd) would be an active & tolerable regimen in pts with heavily pre-treated MM. 78% ORR & overall PFS of 23 months were obtained #mmsm, #myeloma, @DukeCancer

by | Jun 12, 2021 | Twitter | 0 comments

CONGRESS|#EHA2021|@Cristin53875581, determined that the addition of QW SEL to the PI carfilzomib (CAR)-dex (XKd) would be an active & tolerable regimen in pts with heavily pre-treated MM. 78% ORR & overall PFS of 23 months were obtained #mmsm, #myeloma, @DukeCancer https://t.co/E1SeBHvLj4 pic.twitter.com/XN5kNsI5KC

— Multiple Myeloma Hub (@MM_Hub) June 12, 2021

Submit a Comment